Semaglutide: a gendered phenomenon—women’s increased vulnerability to adverse drug reactions in the global weight loss trend
Saved in:
| Main Authors: | Eleonora Castellana, Maria Rachele Chiappetta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Drug Safety |
| Online Access: | https://doi.org/10.1177/20420986251332737 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting retinal angiogenesis: sex differences in adverse reactions to anti-VEGF therapies
by: Eleonora Castellana, et al.
Published: (2025-07-01) -
Semaglutide: muscle loss and the ugly truth behind the weight loss trend
by: Rodrigo Terán-Garza, et al.
Published: (2025-04-01) -
From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
by: Rawan Othman
Published: (2025-08-01) -
IMPACT OF CELEBRITY STATEMENTS ON INTERNET SEARCHES ON THE USE OF SEMAGLUTIDE FOR WEIGHT LOSS
by: S. PROVENZANO, et al.
Published: (2025-07-01) -
Alopecia areata following semaglutide treatment for weight loss: A case report
by: Wasan S. Alzahrani, MBBS, et al.
Published: (2025-09-01)